Where is the market heading?
In this interview for Switzer TV, Roger joins Peter Switzer to discuss exactly where the market is at right now. Low interest rates are pushing equities higher creating a challenge for value investors. Although, if we take a look overseas, there are a lot more opportunities.
Roger Montgomery is the Founder and Chairman of Montgomery Investment Management. Roger has over three decades of experience in funds management and related activities, including equities analysis, equity and derivatives strategy, trading and stockbroking. Prior to establishing Montgomery, Roger held positions at Ord Minnett Jardine Fleming, BT (Australia) Limited and Merrill Lynch.
This post was contributed by a representative of Montgomery Investment Management Pty Limited (AFSL No. 354564). The principal purpose of this post is to provide factual information and not provide financial product advice. Additionally, the information provided is not intended to provide any recommendation or opinion about any financial product. Any commentary and statements of opinion however may contain general advice only that is prepared without taking into account your personal objectives, financial circumstances or needs. Because of this, before acting on any of the information provided, you should always consider its appropriateness in light of your personal objectives, financial circumstances and needs and should consider seeking independent advice from a financial advisor if necessary before making any decisions. This post specifically excludes personal advice.
Gary Heath
:
Hi Roger,
I have followed and listened to you for many years and have met you once over 10 years ago at an investment seminar in melbournes convention centre. Keep up the great work you do!
I have been a long term holder of a small but exciting up and coming company that will help millions of asthmatics to monitor their disease which will be lifesaving for many around the world. The many many years of ground work and trials to deliver this unique (nothing in the world like it) device called ‘wheezo’ is about to come together between now and Xmas to begin making revenues that could be staggering over many years. The device is about to be manufactured but is also awaiting the important CE mark of approval for the UK and Europe as well as the USA etc.
The western world currently has 400 million asthmatics of which 250,000 die annually. On top of those figures the world has India , China and the African countries all with massive asthma problems. I do not work for the company and do not work in anyway in this industry or sales or anything related but believe this device will save many lives. I am a shareholder that likes your investment style. Definitely worth investigating the enormous potential here!
The company name is RESPIRI code RSH a medtech stock in the same sector as Resmed and Cochlear and CSL .
A very exciting time.
Kind Regards,
Gary